BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33948392)

  • 1. Identification and characterization of B220
    Zhang Z; Huang X; Wang E; Huang Y; Yang R
    Oncoimmunology; 2021 Apr; 10(1):1912472. PubMed ID: 33948392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD205
    Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S
    Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Role of CD11b
    Wu SY; Chiang CS
    Cells; 2019 Dec; 9(1):. PubMed ID: 31878276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
    Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-223 suppresses differentiation of tumor-induced CD11b⁺ Gr1⁺ myeloid-derived suppressor cells from bone marrow cells.
    Liu Q; Zhang M; Jiang X; Zhang Z; Dai L; Min S; Wu X; He Q; Liu J; Zhang Y; Zhang Z; Yang R
    Int J Cancer; 2011 Dec; 129(11):2662-73. PubMed ID: 21213211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related expansion and increased osteoclastogenic potential of myeloid-derived suppressor cells.
    Li Z; Zhao Y; Chen Z; Katz J; Michalek SM; Li Y; Zhang P
    Mol Immunol; 2021 Sep; 137():187-200. PubMed ID: 34274794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 Directs the Mobilization of CD11b
    Hawila E; Razon H; Wildbaum G; Blattner C; Sapir Y; Shaked Y; Umansky V; Karin N
    Cell Rep; 2017 Nov; 21(8):2212-2222. PubMed ID: 29166611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b
    Takahashi R; Amano H; Ito Y; Eshima K; Satoh T; Iwamura M; Nakamura M; Kitasato H; Uematsu S; Raouf J; Jakobsson PJ; Akira S; Majima M
    Biomed Pharmacother; 2020 Jan; 121():109581. PubMed ID: 31715374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
    Spallanzani RG; Dalotto-Moreno T; Raffo Iraolagoitia XL; Ziblat A; Domaica CI; Avila DE; Rossi LE; Fuertes MB; Battistone MA; Rabinovich GA; Salatino M; Zwirner NW
    Cancer Immunol Immunother; 2013 Dec; 62(12):1781-95. PubMed ID: 24114144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of Ly6G
    Heim CE; West SC; Ali H; Kielian T
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.
    Fujikawa Y; Sendo S; Del Peral Fanjul A; Yamada H; Uto K; Yamamoto Y; Nagamoto T; Morinobu A; Saegusa J
    Front Immunol; 2024; 15():1168323. PubMed ID: 38566990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
    Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
    Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection.
    Cuervo H; Guerrero NA; Carbajosa S; Beschin A; De Baetselier P; Gironès N; Fresno M
    J Immunol; 2011 Sep; 187(5):2656-65. PubMed ID: 21804013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-Derived Suppressor Cells in
    Fresno M; Gironès N
    Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
    Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.